ITIH2 and preeclampsia: In addition, findings from this study shed light on determining if high Itih2 levels serve as a biomarker for poor outcomes, similar to that described for other disease states (preeclampsia [44,45]), or mechanistically targeting reducing the inhibitory function of Itih2 to stabilize AoV ECM homeostasis.